I believe in remote human possibilities and the almost infinite potential of the individual. To me, it’s clear that people matter most of all.
I’ve always wanted to understand how the mind works. In college, I studied computational neuroscience, worked in a primate cognition lab, and graduated with a degree in computer science. My first real job was writing software to simulate computer networks. It was amazing to me how well simulation works, that you can create a faithful representation of a system, simulate its dynamics, and learn meaningful things about the real live system. If this works so well for computer networks (and bridges, airplanes, autonomous vehicles, etc.), why shouldn’t it work for biology?
This question and the desire to simulate biological systems led me to Caltech, where I enrolled in a biophysics PhD program. I worked in an early cryo-EM lab where we looked at the simplest cells in 3D. I built computational models to simulate tiny pieces of these cells. The work was fascinating but disconnected from the realities of the human condition. Academic science is slow and careful. While professors compete for limited resources, people are dying. I began to realize the best way for me to have an impact and help people is to accelerate biomedical innovation.
My desire to make the future happen faster is how I discovered startups. Shortly after, I left grad school (with some papers, but no degree) and started a biosensor company with a couple of friends. We raised funding from great investors and hired the most talented scientists and engineers, however we ultimately failed. Democratizing diagnostics is a worthwhile mission, but a challenging business. From there, I found my way into investing and it’s a perfect fit. Backing brilliant founders who are innovating at the forefront of biomedicine feels like a force multiplier for good.
I began my venture career at Innovation Endeavors, investing at the intersection of data science and life science. After that, I worked at CRV and helped build the firm’s bioengineering practice. I came to Insight in July 2021 to lead our emerging efforts in the bio space. My team and I love technology-enabled approaches to drug discovery and development, new therapeutic modalities, and especially curative therapies.
Bring us your wildest ideas but show us how you will reduce them to practice. We’re here and ready to listen.
I’ve always wanted to understand how the mind works. In college, I studied computational neuroscience, worked in a primate cognition lab, and graduated with a degree in computer science. My first real job was writing software to simulate computer networks. It was amazing to me how well simulation works, that you can create a faithful representation of a system, simulate its dynamics, and learn meaningful things about the real live system. If this works so well for computer networks (and bridges, airplanes, autonomous vehicles, etc.), why shouldn’t it work for biology?
This question and the desire to simulate biological systems led me to Caltech, where I enrolled in a biophysics PhD program. I worked in an early cryo-EM lab where we looked at the simplest cells in 3D. I built computational models to simulate tiny pieces of these cells. The work was fascinating but disconnected from the realities of the human condition. Academic science is slow and careful. While professors compete for limited resources, people are dying. I began to realize the best way for me to have an impact and help people is to accelerate biomedical innovation.
My desire to make the future happen faster is how I discovered startups. Shortly after, I left grad school (with some papers, but no degree) and started a biosensor company with a couple of friends. We raised funding from great investors and hired the most talented scientists and engineers, however we ultimately failed. Democratizing diagnostics is a worthwhile mission, but a challenging business. From there, I found my way into investing and it’s a perfect fit. Backing brilliant founders who are innovating at the forefront of biomedicine feels like a force multiplier for good.
I began my venture career at Innovation Endeavors, investing at the intersection of data science and life science. After that, I worked at CRV and helped build the firm’s bioengineering practice. I came to Insight in July 2021 to lead our emerging efforts in the bio space. My team and I love technology-enabled approaches to drug discovery and development, new therapeutic modalities, and especially curative therapies.
Bring us your wildest ideas but show us how you will reduce them to practice. We’re here and ready to listen.
